Cardiovascular Protection by Initial and Subsequent Combination of Antihypertensive Drugs in Daily Life Practice

No abstract is available for this paper.

• Publication year

  2011

• Venue

  HYPERTENSION

• Publication date

  2011-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/HYPERTENSIONAHA.111.177592PMID 21825231
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Overview of Automated Databases in Pharmacoepidemiology

  2013cited by this paper
• Blood pressure control by the nifedipine GITS–telmisartan combination in patients at high cardiovascular risk: the TALENT study

  2011cited by this paper
• Reduced discontinuation of antihypertensive treatment by two-drug combination as first step. Evidence from daily life practice

  2010cited by this paper
• Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 Trials

  2010cited by this paper
• The Clock Is Ticking: The Case for Achieving More Rapid Control of Hypertension

  2010cited by this paper
• Effect of Intensive Versus Standard Blood Pressure Lowering on Diastolic Function in Patients With Uncontrolled Hypertension and Diastolic Dysfunction

  2010cited by this paper
• Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials.

  2009cited by this paper
• Do socioeconomic disparities affect accessing and keeping antihypertensive drug therapy? Evidence from an Italian population-based study

  2009cited by this paper
• The effect of discontinuation of antihypertensives on the risk of acute myocardial infarction and stroke

  2008cited by this paper
• 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

  2008cited by this paper
• Pharmacoepidemiological research and the linking of electronic healthcare databases available in the Italian region of Lombardy

  2008cited by this paper
• Time to achieve blood-pressure goal: influence of dose of valsartan monotherapy and valsartan and hydrochlorothiazide combination therapy.

  2007cited by this paper
• Exceptional early blood pressure control rates: The ACCOMPLISH trial

  2007cited by this paper
• 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

  2007cited by this paper
• Persistence with oral and transdermal hormone replacement therapy and hospitalisation for cardiovascular outcomes.

  2007cited by this paper
• Improvement in hypertension management in England: results from the Health Survey for England 2003

  2006cited by this paper
• The importance of early antihypertensive efficacy: the role of angiotensin II receptor blocker therapy

  2006cited by this paper
• Blockade of angiotensin II provides additional benefits in hypertension- and ageing-related cardiac and vascular dysfunctions beyond its blood pressure-lowering effects

  2005cited by this paper
• The Efficacy and Safety of Low‐ and High‐ Dose Fixed Combinations of Irbesartan/Hydrochlorothiazide in Patients With Uncontrolled Systolic Blood Pressure on Monotherapy: The INCLUSIVE Trial

  2005cited by this paper
• Initial treatment of hypertension and adherence to therapy in general practice in Italy

  2005cited by this paper
• Monte Carlo sensitivity analysis and Bayesian analysis of smoking as an unmeasured confounder in a study of silica and lung cancer.

  2004cited by this paper
• Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial.

  2004cited by this paper
• Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

  2003cited by this paper
• Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials

  2003cited by this paper
• Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.

  2003cited by this paper
• Sensitivity Analysis, Monte Carlo Risk Analysis, and Bayesian Uncertainty Assessment

  2001cited by this paper
• Statistical methods in cancer research

  2001cited by this paper
• Multinational comparisons of stroke epidemiology. Evaluation of case ascertainment in the WHO MONICA Stroke Study. World Health Organization Monitoring Trends and Determinants in Cardiovascular Disease.

  1995cited by this paper
• Myocardial Infarction and Coronary Deaths in the World Health Organization MONICA Project: Registration Procedures, Event Rates, and Case‐Fatality Rates in 38 Populations From 21 Countries in Four Continents

  1994cited by this paper
• Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

  1992cited by this paper
• Statistical methods in cancer research. Vol. 1. The analysis of case-control studies.

  1981cited by this paper
• The analysis of case-control studies

  1980cited by this paper

• Use of Quadruple Therapy in the Management of Hypertension: A Systematic Review of Randomized Controlled Trials

  2025cites this paper
• Effects of Two Allisartan Isoproxil‐Based Antihypertensive Therapies on Sexual Function and Blood Pressure in Male Hypertensive Patients: A Single‐Center, Open‐Label, and Randomized Controlled Trial

  2025cites this paper
• Trends in first‐line monotherapy and combination therapy for hypertension in UK primary care

  2025cites this paper
• Long-term event rates, risk factors, and treatment pattern in 1.4 million individuals qualifying for dual blood pressure lowering therapy

  2025cites this paper
• Initial treatment with a single capsule containing half-dose quadruple therapy vs standard-dose dual therapy in hypertensive patients (QUADUAL): a randomized, blinded, crossover trial

  2025cites this paper
• Blood pressure control in the hypertensive population. Factors involved and perspectives.

  2024cites this paper
• Simplified Approach to Managing Newly Diagnosed Patients with Mild-to-Moderate Hypertension in Routine Clinical Practice

  2024cites this paper
• [Hypertension: Who to treat, to what extent and how?]

  2023cites this paper
• Telmisartan Plus Amlodipine as the Preferred Initial Combination in Newly Diagnosed Indian Patients with Hypertension: An Expert Consensus Statements.

  2023cites this paper
• Home Blood Pressure Telemonitoring Technology for Patients With Asymptomatic Elevated Blood Pressure Discharged From the Emergency Department: Pilot Study

  2023cites this paper
• A Randomized, Multicenter, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a Quadruple Combination of Amlodipine, Losartan, Rosuvastatin, and Ezetimibe in Patients with Concomitant Essential Hypertension and Dyslipidemia

  2023cites this paper
• 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the European Renal Association (ERA) and the International Society of Hypertension (ISH).

  2023cites this paper
• Initial treatment with a single capsule containing half-dose quadruple therapy versus standard-dose dual therapy in hypertensive patients (QUADUAL): Study protocol for a randomized, blinded, crossover trial.

  2023cites this paper
• Hypertension artérielle : qui traiter, jusqu’où et comment ?

  2023cites this paper
• Building reliable evidence from real-world data: methods, cautiousness and recommendations

  2022cites this paper
• TIMES TO ACT. Italian-Spanish-Polish-Uzbek Expert Forum Position Paper 2022. Dyslipidemia and arterial hypertension: The two most important and modifiable risk factors in clinical practice

  2022cites this paper
• Use of initial and subsequent antihypertensive combination treatment in the last decade: analysis of a large Italian database

  2022cites this paper
• 2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension.

  2022cites this paper
• Effect of auricular plaster for primary hypertension in older people: A meta-analysis

  2022cites this paper
• Implementing Single-Pill Combination Therapy for Hypertension: A Scoping Review of Key Health System Requirements in 30 Low- and Middle-Income Countries

  2022cites this paper
• Concomitant Treatment of Hypertensive Patients with Bisoprolol and Perindopril in Routine Clinical Practice: A Post Hoc Analysis of the CONFIDENCE II, PROTECT I, and PROTECT III Observational Studies

  2021cites this paper
• THE APPLICATION OF COMBINED PREPARATIONS WITH CONSTANT DOSES OF ANTIHYPERTENSIVE DRUGS AS THE INITIAL TACTICS OF TREATMENT AT HIGH BLOOD PRESSURE LEVEL: PROVEN FACTS AND EXPERT’S OPINION

  2021cites this paper
• A systematic review of quantitative bias analysis applied to epidemiological research.

  2021cites this paper
• Projecting the long-term benefits of single pill combination therapy for patients with hypertension in five countries

  2020cites this paper
• ‘ ‘ Combinations in hypertension and cardiovascular prevention : are they additive or synergistic ?

  2020cites this paper
• The use of single-pill combinations as first-line treatment for hypertension: translating guidelines into clinical practice.

  2020cites this paper
• New approach to blood pressure control: Triple combination pill.

  2020cites this paper
• Design: Sampling, Clinical Trials

  2019cites this paper
• Extrusion-Based 3D Printing for Pharmaceuticals: Contemporary Research and Applications.

  2019cites this paper
• Two-Drug Combinations as First-Step Antihypertensive Treatment.

  2019cites this paper
• Blood pressure distribution and control in coronary patients from 24 European countries in the European Society of Cardiology EURoObservational Research Programme European survey of cardiovascular disease prevention and diabetes. EUROASPIRE IV Registry.

  2019cites this paper
• Matriz de recomendações para farmacoterapia da Hipertensão Arterial Sistêmica: recurso para subsidiar a adaptação de guias de prática clínica

  2019cites this paper
• Effectiveness of two‐drug therapy versus monotherapy as initial regimen in hypertension: A propensity score‐matched cohort study in the UK Clinical Practice Research Datalink

  2019cites this paper
• Fixed Versus Free Combinations Of Antihypertensive Drugs: Analyses Of Real-World Data Of Persistence With Therapy In Italy

  2019cites this paper
• Combination Antihypertensive Therapy Prescribing and Blood Pressure Control in a Real-World Setting.

  2019influential citation
• ACE-inhibitor/calcium antagonist combination: is this the first-choice therapy in arterial hypertension?

  2019cites this paper
• NOVEL EXPERIENCE WITH COMBINED FIX-DOSE THERAPY FOR HYPERTENSION

  2019cites this paper
• Fixed Versus Free Combinations Of Antihypertensive Drugs: Analyses Of Real-World Data Of Persistence With Therapy In Italy

  2019cites this paper
• Calcium Channel Blockers for the Clinical Management of Hypertension

  2018cites this paper
• Effectiveness of a Fixed-Dose, Single-Pill Combination of Perindopril and Amlodipine in Patients with Hypertension: A Non-Interventional Study

  2018cites this paper
• Comparison Therapies in the Treatment of Hypertension. The ASCOT and ACCOMPLISH Trial

  2018cites this paper
• Trends in the prevalence of antihypertensive drug treatment in the Beijing Longitudinal Study of Aging.

  2018cites this paper
• Program CANVAS : Canagliflozin – kardiovaskulární a renální vliv u diabetes mellitus 2

  2018cites this paper
• 50 – Updated American Heart Association/American College of Cardiology; European Society of Hypertension/International Society of Hypertension Guidelines

  2018cites this paper
• Single-Pill Combinations in the Treatment of Hypertension in Adults: Beyond Convenience.

  2018cites this paper
• Combination therapies for hypertension – why we need to look beyond RAS blockers

  2018cites this paper
• Adherence to Antihypertensive and Cardiovascular Preventive Treatment: The Contribution of the Lombardy Database

  2018cites this paper
• Hypertension Canada’s 2017 guidelines for diagnosis, risk assessment, prevention and treatment of hypertension in adults for pharmacists: An update

  2018cites this paper
• Early cardiovascular protection by initial two-drug fixed-dose combination treatment vs. monotherapy in hypertension

  2018cites this paper
• Attitudes and preferences for the clinical management of hypertension and hypertension-related cerebrovascular disease in the general practice: results of the Italian hypertension and brain survey

  2017cites this paper
• Towards a mobile system for hypertensive outpatients' treatment adherence improvement

  2017cites this paper
• The polypill in cardiovascular prevention: evidence, limitations and perspective - position paper of the European Society of Hypertension.

  2017cites this paper
• Practical Applications for Single Pill Combinations in the Cardiovascular Continuum.

  2017cites this paper
• A quarter-dose quadpill for initial treatment of hypertension.

  2017cites this paper
• Blood pressure control in hypertension. Pros and cons of available treatment strategies.

  2017cites this paper
• Combination therapy for hypertension with a focus on fixed combinations

  2017cites this paper
• Single-pill combinations (SPCs) and treatment of arterial hypertension in Poland. Expert consensus statement of the Polish Society of Hypertension and Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy.

  2017cites this paper
• Clinical Study of Cardiac Markers in Post Myocardial Infarction Patients on Antihypertensive Drug Therapy

  2017cites this paper
• [Combination for initial therapy in hypertension, is it useful?]

  2017cites this paper
• Kombinační léčba hypertenze v roce 2017 – minimum pro farmaceuty

  2017cites this paper
• Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults.

  2017cites this paper
• Leki złożone w terapii nadciśnienia tętniczego w Polsce. Stanowisko Ekspertów Polskiego Towarzystwa Nadciśnienia Tętniczego oraz Sekcji Farmakoterapii Sercowo-Naczyniowej Polskiego Towarzystwa Kardiologicznego

  2017cites this paper
• A System for Hypertension Management Assistance Based on the Technologies of the Smart Spaces

  2016cites this paper
• Probabilistic bias analysis in pharmacoepidemiology and comparative effectiveness research: a systematic review

  2016cites this paper
• Dose–response effect of the lercanidipine/enalapril combination: a pooled analysis

  2016cites this paper
• Asthma Associates With Human Abdominal Aortic Aneurysm and Rupture

  2016cites this paper
• Current approaches to combination therapy of hypertension

  2016cites this paper
• [The Use of Fixed Perindopril A/Amlodipine Combination Provides High Compliance to Therapy, Effective and Safe Arterial Pressure Lowering in Patients With Previous Inefferctive Therapy. The POTENTIAL Program].

  2015cites this paper
• Attitudes and preferences for the clinical management of patients with hypertension and hypertension with chronic obstructive pulmonary disease in Italy: main results of a survey questionnaire

  2015cites this paper
• Blood pressure reduction and control with fixed-dose combination perindopril/amlodipine: A Pan-Hellenic prospective observational study

  2015cites this paper
• Short- and long-term mortality and hospital readmissions among patients with new hospitalization for heart failure: A population-based investigation from Italy.

  2015cites this paper
• Combination Therapy in Hypertension: What Are the Best Options According to Clinical Pharmacology Principles and Controlled Clinical Trial Evidence?

  2015cites this paper
• Safety of Fixed Dose of Antihypertensive Drug Combinations Compared to (Single Pill) Free-Combinations

  2015cites this paper
• Target organ damage and control of cardiovascular risk factors in hypertensive patients

  2015cites this paper
• The pharmacokinetic–pharmacodynamic model of telmisartan and hydrochlorothiazide on blood pressure and plasma potassium after long‐term administration in spontaneously hypertensive rats

  2015cites this paper
• 2015 guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the management of hypertension.

  2015cites this paper
• Comparison of single-pill strategies first line in hypertension: perindopril/amlodipine versus valsartan/amlodipine

  2015cites this paper
• Comparison of single-pill strategies first line in hypertension: perindopril/amlodipine versus valsartan/amlodipine.

  2015cites this paper
• Comparison of single-pill strategies first line in hypertension: perindopril/amlodipine versus valsartan/amlodipine.

  2015cites this paper
• Study Design: Sampling, Clinical Trials

  2015cites this paper
• Generating evidence from computerized healthcare utilization databases.

  2015cites this paper
• Drug therapy for the patient with resistant hypertension.

  2015cites this paper
• Effect of initial antihypertensive combination therapy on primary stroke prevention.

  2015cites this paper
• Antihypertensive Medications, Loop Diuretics, and Risk of Hip Fracture in the Elderly: A Population-Based Cohort Study of 81,617 Italian Patients Newly Treated Between 2005 and 2009

  2015cites this paper
• Appraisal of the Clinical Trial Data on Renal Denervation for the Management of Resistant Hypertension

  2015cites this paper
• Effect of initial antihypertensive combination therapy on primary stroke prevention

  2015cites this paper
• Trends in Hypertension Control Among the Older Population of Spain From 2000 to 2001 to 2008 to 2010: Role of Frequency and Intensity of Drug Treatment

  2015cites this paper
• A guide for easy- and difficult-to-treat hypertension.

  2014cites this paper
• Burden of new hospitalization for heart failure: a population‐based investigation from Italy

  2014cites this paper
• Treatment: Recent Clinical Trials

  2014cites this paper
• Increasing appreciation for the role of single-pill combinations for the prevention of atherosclerotic disease: a pro-polypill polemic.

  2014cites this paper
• The Use of Left Ventricular Myocardial Stiffness Index as a Predictor of Myocardial Performance in Patients with Systemic Hypertension

  2014cites this paper
• Inhibitory ACE, nebo sartany v léčbě hypertenze: zbytečná diskuse?

  2014cites this paper
• Clinical Management of Patients with Hypertension and High Cardiovascular Risk

  2014cites this paper
• Correction: Blood Pressure Control with a Single-Pill Combination of Indapamide Sustained-Release and Amlodipine in Patients with Hypertension: The EFFICIENT Study

  2014cites this paper
• Attitudes and preferences for the clinical management of hypertension and hypertension-related cardiac disease in general practice: results of the Italian Hypertension and Heart Survey

  2014cites this paper
• Blood Pressure Control with a Single-Pill Combination of Indapamide Sustained-Release and Amlodipine in Patients with Hypertension: The EFFICIENT Study

  2014cites this paper
• Efficacy and Tolerability of Telmisartan Plus Amlodipine in Asian Patients Not Adequately Controlled on Either Monotherapy or on Low-Dose Combination Therapy

  2014cites this paper
• [Current management of arterial hypertension].

  2014cites this paper
• Azilsartan/chlorthalidone combination therapy for blood pressure control

  2013cites this paper